Switzerland and Canada are among the five international medicines regulators involved in the ACCESS Consortium and Project Orbis, two separate coalitions that were established with the goal of speeding up and harmonizing the regulatory review processes at international level.
There are some key differences between Project Orbis and the ACCESS Consortium. The biggest is that Project Orbis is directed...








